Cusatuzumab in Combination With Background Therapy for the Treatment of Participants With Acute Myeloid Leukemia
Clinical trial NCT04150887 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04150887
- Sponsor
- OncoVerity, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-23
- Primary completion
- 2027-05-15
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.